Latest filing published 31 May 2022 for Xvivo Perfusion AB, €17k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +8.4%Entry 11.77 · Close at T+365 12.76
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Christoffer Björn Rosenblad: trading record in brief
All filings by Christoffer Björn Rosenblad on record concern Xvivo Perfusion AB. Between 2 June 2017 and 31 May 2022, the trades on record add up to 6 filings.
In open-market terms, that means 3 purchases worth €32k on one side and 1 sale worth €89k on the other. The net balance comes to €57k on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2022: 1 purchase and no sales on the market.
A typical purchase (the median) is worth €12k.
Most recently, on 31 May 2022, the filings show an open-market purchase worth €17k in Xvivo Perfusion AB. Filings reach the Finansinspektionen feed a median of 1 day after the trade. For comparison, MAR article 19 gives managers three business days to notify a trade. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Companies and markets linked to Christoffer Björn Rosenblad
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ SEK 17.9212.7% of flowTeckningsoptionFI:csv-addf7c71f99c512bb6bcCanonical exit: 29 Aug 2022 (T+90)
- 7,500 shares@ SEK 16.319.8% of flowTeckningsoptionFI:csv-41b878962d28b62ea5b1
- 18,000 shares@ SEK 0.65351.2% of flowFI:csv-d0f39e7163b55ffb6cda
- 18,000 shares@ SEK 1.753.5% of flowFI:csv-227c0bd81620ab00d4caCanonical exit: 3 Sept 2017 (T+90)
- 26,000 shares@ SEK 33.416295.3% of flowFI:csv-695ee808017906adc9a5
5 of 5 declarations